623-78-9CCNC(=O)OCCGZXSDYYWLZERLF-UHFFFAOYSA-N623-78-9DTXSID0060775Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P203, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
THE TUMOR INITIATING POTENCY OF ETHYL CARBAMATE HOMOLOGS & ETHYL CARBAMATE N-SUBSTITUTED DERIVATIVES WERE STUDIED AFTER SUBCUTANEOUS INJECTION INTO MICE FOLLOWED BY TREATMENT WITH THE PROMOTER CROTON OIL. THE TUMOR INITIATING POTENCIES WERE, IN DESCENDING ORDER ETHYL CARBAMATE, ETHYL N-METHYLCARBAMATE, ETHYL N-ETHYLCARBAMATE, & BUTYL CARBAMATE.
2 MG/KG OF ETHYL URETHANE GIVEN SUBCUTANEOUSLY TO MICE INCREASED THE ELECTROCARDIOGRAM PERIOD. BRADYCARDIA PHASES WITH INCREASED ARRHYTHMIA ALTERNATED WITH ACCELERATED & MORE REGULAR PERIODS.
AT 0.25% N-ETHYLURETHANE INDUCED ABNORMALITIES IN THE NERVOUS SYSTEM OF CULTIVATED CHICK EMBRYOS, IN WHICH THE FORE, MID, & HIND BRAIN REGIONS WERE NOT DIFFERENTIATED.
Used as an experimental neoplastic agent; No known commercial production in the US; [HSDB]
MEDICATION
RESEARCH CHEMICAL (EXPTL NEOPLASTIC AGENT)
(1979) No Data
(1981) No Data
(1979) No Data
(1981) No Data
(1979) NOT PRODUCED COMMERCIALLY IN U.S.
(1981) NOT PRODUCED COMMERCIALLY IN U.S.
Wird geladen…